Labixiaoxin Issues 20.83 Million New Shares, Enlarging Capital Base by 9.54%
Bulletin Express
Mar 31
Labixiaoxin Snacks Group Limited disclosed through a Next Day Disclosure Return (31 March 2026) that it has issued 20.83 million ordinary shares as consideration shares under a sale-and-purchase agreement dated 5 February 2026.
The new shares were allotted on 31 March 2026 at HKD 3.98 per share, bringing in approximately HKD 82.92 million. Following the issuance, Labixiaoxin’s outstanding share capital increased from 218.42 million to 239.25 million shares, representing a 9.54% expansion.
The filing confirms that the transaction was duly authorised by the board and complied with all relevant listing rules and regulatory requirements. No treasury shares were issued, sold, or repurchased during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.